Sanguine Biosciences Achieves ISO Certifications for Quality
![Sanguine Biosciences Achieves ISO Certifications for Quality](https://investorshangout.com/images/blog/ihnews-Sanguine%20Biosciences%20Achieves%20ISO%20Certifications%20for%20Quality.jpg)
Sanguine Biosciences Achieves ISO Certifications
Sanguine Biosciences is a pioneering biospecimen procurement company dedicated to personalized medicine and biomedical research. Recently, it achieved three significant ISO certifications: ISO 9001, ISO 27001, and ISO 27701. These certifications emphasize Sanguine's unwavering commitment to quality, information security, and privacy management.
Commitment to Quality Management
The ISO 9001 certification validates Sanguine's robust quality management system (QMS). Brian Neman, the CEO of Sanguine Biosciences, proudly shared that this achievement showcases their relentless pursuit of excellence across all business areas. The certification ensures that Sanguine maintains the highest standards of quality, which is crucial for customer satisfaction.
Focus on Information Security
In an era marked by escalating data breaches and security threats, Sanguine's ISO 27001 certification represents a pivotal accomplishment. Gerald Lee, the company’s Chief Privacy Officer (CPO), highlighted the importance of safeguarding information assets, stating that achieving ISO 27001 certification demonstrates their dedication to protecting the data of customers, partners, and donors with the utmost security.
Prioritizing Privacy Compliance
Alongside its focus on quality and information security, Sanguine places a strong emphasis on privacy management. AnnMarie Fleshman, the Vice President of Quality and Compliance, explained that privacy is a fundamental right. The ISO 27701 certification signifies their commitment to handling personal data responsibly, reassuring customers that their information is treated with care.
Significance of Latest ISO Certifications
The trio of ISO certifications serves as a testament to Sanguine's rigorous standards. They assure customers and partners of the company’s reliable processes and practices. With ISO certifications reinforcing its dedication to excellence, Sanguine is poised to introduce Good Manufacturing Practices (GMP) products in the near future.
About Sanguine Biosciences
Sanguine Biosciences is at the forefront of enhancing personalized medicine through the empowerment of individuals with their healthcare data. By facilitating participation in biomedical research, the company merges annotated biospecimens with real-world data, playing a vital role in biomarker discovery and validation studies. Sanguine supports translational and clinical research for over 30 leading pharmaceutical and biotechnology companies globally, accelerating research and development and enhancing drug manufacturing pipelines.
Sanguine’s commitment to a positive working environment has earned it recognition as a "Great Place to Work" for four consecutive years. The company also made it onto the list of Inc. 5000 America's Fastest Growing Private Companies and received accolades as one of Fortune's Best Workplaces in BioPharma and Best Small Workplaces.
Frequently Asked Questions
What ISO certifications did Sanguine Biosciences achieve?
Sanguine Biosciences achieved ISO 9001, ISO 27001, and ISO 27701 certifications.
Why are these certifications significant?
These certifications validate Sanguine's commitment to quality management, information security, and privacy management, enhancing trust among customers and partners.
What does the ISO 9001 certification signify?
The ISO 9001 certification signifies that Sanguine maintains high standards in their quality management system, ensuring customer satisfaction.
How does Sanguine ensure data security?
Sanguine follows stringent protocols and achieved ISO 27001 certification to protect data, addressing rising concerns about data breaches and security threats.
What is the vision of Sanguine Biosciences?
Sanguine aims to accelerate personalized medicine adoption by empowering individuals with their healthcare data and promoting participation in biomedical research.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- ASLA Unveils Transformative 2024 Professional Awards Winners
- Court TV Announces Exciting Fall Primetime Lineup for 2024
- Mediaspace.global Launches Changemakers' Summit for 2024
- MALK Organics Launches Almond Pumpkin Spice for Fall 2024
- Accorto Regulatory Solutions Partners with GINN for Tobacco Safety
- Carterra Ultra™: Transforming Drug Discovery with Precision
- Opus IVS DrivePro 2 Achieves Motor Top 20 Award for 2024
- Autograph Revolutionizes Sports Fandom with New Platform
- Attain Capital Welcomes Former NASA CIO Renee P. Wynn
- ICEYE and Aon Join Forces to Boost Flood and Wildfire Response
- Philadelphia Fed Initiates Search for New President Following Harker
- Blaze Mota Unveils THC-Infused Mota'lada for Everyone
- Adam Neumann and Ryan Serhant to Speak at South Florida Forum
- Growth Prospects for Global Furniture Fittings Market Ahead
- Industrial Cooling Systems Market Set for Remarkable Growth
- Tarkett Receives Platinum Medal from EcoVadis for Sustainability
- Integra LifeSciences Prepares for 2024 Wells Fargo Event
- Gong Named Leader in Revenue Orchestration Platforms by Forrester
- Microban International Partners with CiCLO for Sustainable Textiles
- Autoinjectors Market Forecast to Reach USD 3.02 Billion by 2030
- Middie Rising: A New Narrative for Schools in Transition
- Insider Buying: Two Stocks to Watch for Potential Gains
- 3M Achieves Major Milestone with 300 Million Friction Shims
- Join Us for the 2024 AvaSure Symposium Celebrating Virtual Care
- Yaber Unveils K3 Series Projectors for Home Entertainment
Recent Articles
- Autoinjectors Market Forecast to Reach USD 3.02 Billion by 2030
- Exploring Investment Opportunities in AI: SoundHound and Symbotic
- Yaber Unveils K3 Series Projectors for Home Entertainment
- GT Metabolic™ Solutions Achieves FDA Approval for MagDI™ System
- Plant-Based Food Market to Surge to $113.05 Billion by 2031
- CIBC Mellon, UPP & IMCO to Host Investment Fund Conference
- Norfolk Southern Signs Tentative Agreements with SMART-TD Unions
- Tech Stocks Struggle Amid Economic Growth Concerns
- House Doctors Launches Aging in Place Services Nationwide
- Boeing Sees Stable Delivery Performance Amid Challenges
- Rathbones Group Plc Discloses Position in Balanced Trust
- We Card Awareness Month: Elevating Retailer Training Standards
- Cineverse Expands Data Security with LiveRamp Integration
- Acer Unveils Predator Orion 7000 and Nitro V Gaming Series
- Hedge Funds Show Resilience Amid Market Fluctuations in August
- Thera Finanzen: Europe's Leading Crypto Platform for 2024
- Exploring Top Dividend Stocks: Verizon, J&J, and Nike
- Market Volatility: Recession Fears Impact Investor Confidence
- TeraWulf Provides Update on August 2024 Operations and Production
- Net-Trade.com Celebrated as a Key Influencer in Net Lease
- Panasonic Launches Cutting-Edge OLED and Mini-LED TVs in US
- Travel Retail Market: $152.61 Billion Growth by 2033
- Symphony Talent Unveils SFX Brand Amplifier for Recruitment
- Berkshire Grey Partners with Kardex for Robotic Fulfillment
- Professor Baliga Wins Millennium Technology Prize for Sustainability